Malignant Hematology Administration, H. Lee Moffitt Cancer Center — Tampa, Florida

Malignant Hematology Administration, H. Lee Moffitt Cancer Center is a clinical research site located in Tampa, Florida, United States.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Malignant Hematology Administration, H. Lee Moffitt Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Myelodysplastic Syndromes.

Sponsors: Genzyme, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Malignant Hematology Administration, H. Lee Moffitt Cancer Center?

Malignant Hematology Administration, H. Lee Moffitt Cancer Center has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Malignant Hematology Administration, H. Lee Moffitt Cancer Center conducted?

Malignant Hematology Administration, H. Lee Moffitt Cancer Center has 1 clinical trials on record. Their work covers Myelodysplastic Syndromes.

Is Malignant Hematology Administration, H. Lee Moffitt Cancer Center accredited by Crixeo Health?

Malignant Hematology Administration, H. Lee Moffitt Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Malignant Hematology Administration, H. Lee Moffitt Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.